Jump to ContentJump to Main Navigation
Show Summary Details

Journal of Drug Policy Analysis

A Journal of Substance Abuse Control Policy

Ed. by Kleiman, Mark / Kilmer, Beau

CiteScore 2018: 0.29

SCImago Journal Rank (SJR) 2018: 0.416
Source Normalized Impact per Paper (SNIP) 2018: 0.120

    99,00 € / $149.00 / £80.00*

    See all formats and pricing
    More options …


    Your benefits
    • Interdisciplinary methodology
    • International editorial board
    • Comprehensive outlook on the subject matter
    • Open access publication
    • Ahead of print publishing

    Aims and Scope

    Journal of Drug Policy Analysis (JDPA) publishes peer-reviewed articles related to every aspect of the problems posed by abusable psychoactives, licit and illicit, anywhere in the world. We publish analytic contributions to the public and scholarly conversation about how to deal with the issues surrounding drug policy. Contributions may be data-driven or conceptual, and may incorporate any of the methods of the social and biological sciences, of the professions of medicine, public health, law, law enforcement, and public management, or of the humanities. Contributions will be evaluated purely on their analytic merit, and not on their agreement with the view of the editorial board. It is not necessary that a submission reach a firm policy conclusion; instead, the author may focus on illuminating the stakes in a given policy choice, and the terms of the tradeoffs among the values and interests in play.

    The Journal of Drug Policy Analysis is proud to announce the new Editor’s Choice free access article feature. To download the featured article free of charge, please click the link below.

    Vol 10. Iss. 2 - After the Grand Fracture: Scenarios for the Collapse of the International Drug Control Regime

    Vol 10. Iss. 1 - One Good Decision: The Policy Argument for Extended Release Naltrexone in the Criminal Justice Setting

    Vol 9. Iss. 1 - Reducing Illicit Methamphetamine Labs: Is Precursor Control the Answer?

    Vol 8. Iss. 1 - Will Eric Holder’s Memo Have a Substantial Effect on Civil Asset Forfeiture Practices? by Tyler Kirkland Jones

    What scholars are saying about Journal of Drug Policy Analysis

    The editors and contributors are among the most respected in the field of drug policy. I have no doubt that the journal will be an influence on policymakers and researchers.

    Ralph A. Weisheit, Department of Criminal Justice, Illinois State University

    • Drug abuse policy and control
    • Licit and illicit drugs
    • Drug abuse therapy
    • Drug abuse prevention and drug issues related with Social sciences
    • Biological sciences
    • The humanities
    • Medicine
    • Public health
    • Law enforcement
    • Public management

    Article formats
    Original research articles, book reviews, and commentaries

    Information on submission process


    Type of Publication:

    Drug policy researchers, criminologists, economists, physicians, and policy makers

    Submission of Manuscripts

    Instructions for Authors

    Online Submission of Manuscripts

    Your benefits of publishing with us

    Submission process

    Language Editing
    All manuscripts must be written in clear and concise English. If you have reasons to doubt your proficiency with respect to spelling, grammar, etc. (e.g., because English is not your native language), then you may wish to employ—at your expense—the services of a professional language editor.

    Please get in touch with the Language Editors directly to discuss details.

    • Alexandra Griswold
      Areas of expertise: public policy, political science, education, economics, social sciences, humanities, ethics
    • Cyndy Brown
      Areas of expertise: political science, social sciences, humanities, ethics
    • Donna Reeder
      Areas of expertise: political science, economics, mathematical economics, natural sciences, social sciences, technology, law, humanities, liberal arts, literary studies, health and medicine
    • Dorothy Schepps
      Areas of expertise: political science, emergency management, homeland security, community/land use planning, law, economics, cyber terrorism, and cyber security
    • Jane Cotnoir
      Areas of expertise: Local government management, international crime and terrorism, emergency/disaster management, humanities, social science

    Please note

    We look forward to receiving your manuscript!

    Hybrid Open Access

    For complete details on hybrid open access publishing at De Gruyter please see: https://www.degruyter.com/page/560

    Effective 1st January 2016, authors from an institution affiliated with either the Association of Dutch Universities (VSNU), the Consortium of Swiss Academic Libraries or some UK libraries participating in the Jisc Collections SMP may publish primary research and review articles open access in any of De Gruyter's OnlineOpen journals at a discount of 90% of the APC price. For more information and to confirm whether your institution is eligible please see the following:

    The Netherlands: https://www.degruyter.com/page/1461
    The UK: https://www.degruyter.com/page/1462
    Switzerland: https://www.degruyter.com/page/1463

    More ...


    One issue/year, updated continuously
    ISSN: 1941-2851
    Content available since 2008 (Volume 1, Issue 1)

    Abstracting & Indexing

    Journal of Drug Policy Analysis is covered by the following services:

    • Baidu Scholar
    • Case
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC - cnpLINKer
    • Dimensions
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Genamics JournalSeek
    • Google Scholar
    • IBR (International Bibliography of Reviews of Scholarly Literature in the Humanities and Social Sciences)
    • IBZ (International Bibliography of Periodical Literature in the Humanities and Social Sciences)
    • Japan Science and Technology Agency (JST)
    • J-Gate
    • JournalGuide
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Meta
    • Microsoft Academic
    • MyScienceWork
    • Naviga (Softweco)
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • Publons
    • QOAM (Quality Open Access Market)
    • ReadCube
    • Reaxys
    • SCImago (SJR)
    • SCOPUS
    • Sherpa/RoMEO
    • Summon (ProQuest)
    • TDNet
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • WorldCat (OCLC)

    Editorial Information

    Mark Kleiman, New York University, USA
    Beau Kilmer, RAND Corporation, USA

    Managing Editor
    Deborah Linman, New York University, USA

    Associate Editors
    Jon Caulkins, Carnegie Mellon University, USA
    John Coleman, Drug Watch International, USA
    Philip Cook, Duke University, USA
    David Courtwright, University of North Florida, USA
    Dean Gerstein, Claremont Graduate University, USA
    Angela Hawken, Pepperdine University and University of California, Los Angeles, USA
    Martin Iguchi, University of California, Los Angeles and RAND Corporation, USA
    Jerome Jaffe, University of Maryland, USA
    David Kennedy, John Jay College of Criminal Justice, City University New York, USA
    Andrew Morral, RAND Corporation, USA
    Rosalie Pacula, RAND Corporation, USA
    Letizia Paoli, Catholic University of Leuven, Belgium
    Harold Pollack, University of Chicago, USA
    Rick Rawson, University of California, Los Angeles, USA
    Peter Reuter, University of Maryland and RAND Corporation, USA
    Alison Ritter, University of New South Wales, Australia
    Sally Satel, American Enterprise Institute, USA
    Eric Sevigny, Georgia State University, USA

    Comments (0)

    Please log in or register to comment.
    Log in